Michael Holgate

Michael Holgate is a Partner at Baird Capital based in London, United Kingdom, where he focuses on global buyout and growth capital investments. He specializes in sourcing investments, executing deals, and managing portfolios across the IT Services, Office of the CFO, and Pharma Services sectors. Before joining the private equity firm Baird Capital, Holgate spent two years in the pharmaceutical industry, including a role at GSK, followed by five years working in mergers and acquisitions financial due diligence and corporate finance. He currently holds board seats at four portfolio companies, including Blue Matter, Freemarket, and JMAN, and previously managed successful investments in Crisp and Hopebridge. As a Chartered Accountant with a First Class Masters in chemistry, his current focus centers on supporting technology and services businesses pursuing international expansion across the United States, Europe, and Asia.